Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 May 7;15(1):112.
doi: 10.1186/s13244-024-01697-6.

Optimizing ultrafast dynamic contrast-enhanced MRI scan duration in the differentiation of benign and malignant breast lesions

Affiliations

Optimizing ultrafast dynamic contrast-enhanced MRI scan duration in the differentiation of benign and malignant breast lesions

Ying Cao et al. Insights Imaging. .

Abstract

Objective: To determine the optimal scan duration for ultrafast DCE-MRI in effectively differentiating benign from malignant breast lesions.

Methods: The study prospectively recruited participants who underwent breast ultrafast DCE-MRI from September 2021 to March 2023. A 30-phase breast ultrafast DCE-MRI on a 3.0-T MRI system was conducted with a 4.5-s temporal resolution. Scan durations ranged from 40.5 s to 135.0 s, during which the analysis is performed at three-phase intervals, forming eight dynamic sets (scan duration [SD]40.5s: 40.5 s, SD54s: 54.0 s, SD67.5s: 67.5 s, SD81s: 81.0 s, SD94.5s: 94.5 s, SD108s: 108.0 s, SD121.5s: 121.5 s, and SD135s: 135.0 s). Two ultrafast DCE-MRI parameters, maximum slope (MS) and initial area under the curve in 60 s (iAUC), were calculated for each dynamic set and compared between benign and malignant lesions. Areas under the receiver operating characteristic curve (AUCs) were used to assess their diagnostic performance.

Results: A total of 140 women (mean age, 47 ± 11 years) with 151 lesions were included. MS and iAUC from eight dynamic sets exhibited significant differences between benign and malignant lesions (all p < 0.05), except iAUC at SD40.5s. The AUC of MS (AUC = 0.804) and iAUC (AUC = 0.659) at SD67.5s were significantly higher than their values at SD40.5s (AUC = 0.606 and 0.516; corrected p < 0.05). No significant differences in AUCs for MS and iAUC were observed from SD67.5s to SD135s (all corrected p > 0.05).

Conclusions: Ultrafast DCE-MRI with a 67.5-s scan duration appears optimal for effectively differentiating malignant from benign breast lesions.

Critical relevance statement: By evaluating scan durations (40.5-135 s) and analyzing two ultrafast DCE-MRI parameters, we found a scan duration of 67.5 s optimal for discriminating between these lesions and offering a balance between acquisition time and diagnostic efficacy.

Key points: Ultrafast DCE-MRI can effectively differentiate malignant from benign breast lesions. A minimum of 67.5-sec ultrafast DCE-MRI scan duration is required to differentiate benign and malignant lesions. Extending the scan duration beyond 67.5 s did not significantly improve diagnostic accuracy.

Keywords: Breast neoplasms; Differential diagnosis; Kinetics; Magnetic resonance imaging.

PubMed Disclaimer

Conflict of interest statement

TY is an employee of Siemens Healthineers and DN is an employee of Siemens Healthcare GmbH. The remaining authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Flow diagram of participant selection. n Represents the number of participants, and n* represents the number of lesions
Fig. 2
Fig. 2
Flow chart of ultrafast DCE-MRI data processing. The image set that showed the pre-contrast CS-VIBE was marked as the first phase. The pre-contrast sequences and different phases of post-contrast sequences (1–9, 1–12, 1–15, 1–21, 1–24, 1–27, and 1–30) were used to form eight sets of dynamic series with scan duration ranging from 40.5 s t0 135.0 s. CS-VIBE T1-weighted compressed-sensing volume interpolated breath-hold examination
Fig. 3
Fig. 3
Line plots of ultrafast DCE-MRI parameter values in relation to scan duration for all benign lesions (blue) and malignant lesions (red). MS maximum slope, iAUC initial area under the curve in 60 s
Fig. 4
Fig. 4
A Ultrafast breast DCE-MRI scans in a 49-year-old woman with pathologically confirmed benign fibroadenoma in the right breast. The first two rows (a–h) show color maps of the MS from SD40.5s to SD135s. The last two rows (i–p) show color maps of iAUC from SD40.5s to SD135s. B Ultrafast breast DCE-MRI scans in a 53-year-old woman with pathologically confirmed invasive ductal carcinoma in the left breast. The first two rows (a–h) show color maps of the MS from SD40.5s to SD135s. The last two rows (i–p) show color maps of the iAUC in 60 s from SD40.5s to SD135s. MS maximum slope, iAUC initial area under the curve in 60 s, SD scan duration
Fig. 5
Fig. 5
Graphs show the receiver operating characteristic (ROC) curve of ultrafast DCE-MRI parameters with different scan durations. MS40.5s = MS with a scan duration of 40.5 s, MS54s = MS with a scan duration of 54 s, MS67.5s = MS with a scan duration of 67.5 s, MS81s = MS with a scan duration of 81 s, MS94.5s = MS with a scan duration of 94.5 s, MS108s = MS with a scan duration of 108 s, MS121.5s = MS with a scan duration of 121.5 s, MS135s = MS with a scan duration of 135 s. iAUC definitions for different scan durations are the same as MS above. MS maximum slope, iAUC initial area under the curve in 60 s

References

    1. Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73:17–48. doi: 10.3322/caac.21763. - DOI - PubMed
    1. Mann RM, Hooley R, Barr RG, Moy L. Novel approaches to screening for breast cancer. Radiology. 2020;297:266–285. doi: 10.1148/radiol.2020200172. - DOI - PubMed
    1. Kaiser CG, Reich C, Dietzel M, et al. DCE-MRI of the breast in a stand-alone setting outside a complementary strategy—results of the TK-study. Eur Radiol. 2015;25:1793–1800. doi: 10.1007/s00330-014-3580-4. - DOI - PubMed
    1. Spick C, Szolar DHM, Preidler KW, Tillich M, Reittner P, Baltzer PA. Breast MRI used as a problem-solving tool reliably excludes malignancy. Eur J Radiol. 2015;84:61–64. doi: 10.1016/j.ejrad.2014.10.005. - DOI - PubMed
    1. Bennani-Baiti B, Bennani-Baiti N, Baltzer PA. Diagnostic performance of breast magnetic resonance imaging in non-calcified equivocal breast findings: results from a systematic review and meta-analysis. PLoS One. 2016;11:e0160346. doi: 10.1371/journal.pone.0160346. - DOI - PMC - PubMed

LinkOut - more resources